GE Healthcare has received 510(k) clearance for AI algorithms designed to detect a type of collapsed lung on x-ray images. The FDA clearance covers a set of algorithms that GE has embedded in its Optima XR240amx mobile x-ray device, thereby enabling hospitals to access AI capabilities without investing in IT infrastructure. GE, which claims the system is the first AI-powered x-ray device, said the technology will help hospitals identify high-priority cases and fast track their treatment.
Follow Us
We are a one-stop shop Healthcare Advisory & Consulting boutique and we help businesses with funding, market access, business strategy, distribution.
Categories
Follow Us
Tags
AI
Alzheimer
antibodies
bacteria
binx health
Biosimilar
Blood Filter
Cancer
cardiovascular
cell therapy
CE Mark
clinical trial
colorectal cancer
Diagnostics
Digital Health
Drug Discovery
ExThera Medical
FDA
FDA approval
funding
fundraising
glycosylation
Halodoc
HIV
Innovation
Licensing
M&A
medical device
medtech
microbial
microbial DNA
microbial RNA
microbiome
Neuro
Novartis
pharma
Pharming
Prescient Metabiomics
robots
software
Therapeutics
Therapy
USA
VIrology
women health